No Data
No Data
Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $212
TD Cowen Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $194
ASCENDIS PHARMA Earnings Results: $ASND Reports Quarterly Earnings
Ascendis Pharma Q1 EPS $(1.66) Misses $(1.46) Estimate, Sales $106.16M Beat $94.64M Estimate
Earnings Flash (ASND) Ascendis Pharma A/S Reports Q1 Revenue EUR101M
Ascendis Pharma 1Q Loss/Shr EUR1.58 >ASND